Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rapt Therapeutics Inc (RAPT)

Rapt Therapeutics Inc (RAPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 700,855
  • Shares Outstanding, K 29,647
  • Annual Sales, $ 3,810 K
  • Annual Income, $ -69,200 K
  • 60-Month Beta 0.65
  • Price/Sales 175.18
  • Price/Cash Flow N/A
  • Price/Book 3.97
Trade RAPT with:

Options Overview Details

View History
  • Implied Volatility 95.66% ( -1.63%)
  • Historical Volatility 71.83%
  • IV Percentile 71%
  • IV Rank 20.91%
  • IV High 192.79% on 05/06/22
  • IV Low 69.97% on 08/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 105
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 11,968
  • Open Int (30-Day) 11,853

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.75
  • Number of Estimates 4
  • High Estimate -0.69
  • Low Estimate -0.79
  • Prior Year -0.63
  • Growth Rate Est. (year over year) -19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.28 +40.97%
on 07/29/22
25.57 -4.73%
on 08/11/22
+4.56 (+23.03%)
since 07/11/22
3-Month
10.94 +122.67%
on 05/12/22
25.57 -4.73%
on 08/11/22
+13.20 (+118.28%)
since 05/11/22
52-Week
9.85 +147.18%
on 05/09/22
40.74 -40.21%
on 01/07/22
-8.71 (-26.34%)
since 08/11/21

Most Recent Stories

More News
Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates

Rapt Therapeutics (RAPT) delivered earnings and revenue surprises of 17.33% and 121.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RAPT : 24.36 (+3.05%)
VBLT : 0.2502 (-3.02%)
RAPT Therapeutics Reports Second Quarter 2022 Financial Results

Company maintains strong cash position of $207.3 million...

RAPT : 24.36 (+3.05%)
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 0% and 48.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CLSD : 1.5500 (-4.32%)
RAPT : 24.36 (+3.05%)
Gritstone bio Inc. (GRTS) Reports Q2 Loss, Tops Revenue Estimates

Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 15% and 117.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GRTS : 3.55 (+4.41%)
RAPT : 24.36 (+3.05%)
Regeneron (REGN) Moves 4.4% Higher: Will This Strength Last?

Regeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down...

REGN : 623.90 (-2.74%)
RAPT : 24.36 (+3.05%)
Rapt Therapeutics (RAPT) Reports Q1 Loss, Tops Revenue Estimates

Rapt Therapeutics (RAPT) delivered earnings and revenue surprises of -4.55% and 60.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RAPT : 24.36 (+3.05%)
BIOVF : 23.3250 (+3.67%)
RAPT Therapeutics Reports First Quarter 2022 Financial Results

Company maintains strong cash position of $173.0 million...

RAPT : 24.36 (+3.05%)
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue Estimates

CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of -21.47% and 83.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

CRSP : 77.46 (-1.79%)
RAPT : 24.36 (+3.05%)
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Tops Revenue Estimates

AquaBounty Technologies, Inc. (AQB) delivered earnings and revenue surprises of 12.50% and 31.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

AQB : 1.4400 (+0.70%)
RAPT : 24.36 (+3.05%)
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires

SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based...

RAPT : 24.36 (+3.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193,...

See More

Key Turning Points

3rd Resistance Point 27.20
2nd Resistance Point 26.38
1st Resistance Point 25.37
Last Price 24.36
1st Support Level 23.55
2nd Support Level 22.73
3rd Support Level 21.72

See More

52-Week High 40.74
Fibonacci 61.8% 28.94
Fibonacci 50% 25.30
Last Price 24.36
Fibonacci 38.2% 21.65
52-Week Low 9.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar